ROIV

Roivant Sciences Ltd.NASDAQHealthcare

$28.33+1.76%ClosedMarket Cap: $20.28B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-04	HC Wainwright & Co.	—	Buy	—
2026-02-10	Citigroup	—	Buy	—
2026-02-09	Guggenheim	—	Buy	—
2025-12-15	Leerink Partners	—	Outperform	—
2025-12-15	Goldman Sachs	—	Buy	—
2025-12-12	HC Wainwright & Co.	—	Buy	—
2025-11-11	Citigroup	—	Buy	—
2025-09-18	JP Morgan	—	Overweight	—
2025-09-18	Jefferies	—	Buy	—
2025-09-18	HC Wainwright & Co.	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Wed Mar 31	$-1.18	$44.7M	4
Fri Mar 31	$-1.00	$513.2M	7
Sat Mar 31	$0.28	$1.74B	4
Sun Mar 31	$1.09	$2.99B	2